Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mack Roach

Showing results (191-200 of 284) with videos related to

Pageof 29
Sort By:
Journal of the National Medical Association|March 27, 2003
Radiation medicine innovations for the new milleniumDwight E Heron, Karen D Godette, Ray A Wynn, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA responseSiavash Jabbari, Vivian K Weinberg, Tania Kaprealian, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone, Louis Potters, Brian J Davis, et al.
Journal of Applied Clinical Medical Physics|September 17, 2013
Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnifeMartina Descovich, Mauro Carrara, Sara Morlino, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boostSiavash Jabbari, Vivian K Weinberg, Katsuto Shinohara, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation studyJeff M Michalski, Kyounghwa Bae, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10William U Shipley, J D Lu, Michael V Pilepich, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactionsColleen A Lawton, Michelle DeSilvio, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2012
Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancerCharles C Hsu, Howard Hsu, Barby Pickett, et al.
Pageof 29

Showing results (191-200 of 284) with videos related to

Sort By:
Pageof 29
Journal of the National Medical Association|March 27, 2003
Radiation medicine innovations for the new milleniumDwight E Heron, Karen D Godette, Ray A Wynn, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA responseSiavash Jabbari, Vivian K Weinberg, Tania Kaprealian, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone, Louis Potters, Brian J Davis, et al.
Journal of Applied Clinical Medical Physics|September 17, 2013
Improving plan quality and consistency by standardization of dose constraints in prostate cancer patients treated with CyberKnifeMartina Descovich, Mauro Carrara, Sara Morlino, et al.
International Journal of Radiation Oncology, Biology, Physics|May 5, 2009
Equivalent biochemical control and improved prostate-specific antigen nadir after permanent prostate seed implant brachytherapy versus high-dose three-dimensional conformal radiotherapy and high-dose conformal proton beam radiotherapy boostSiavash Jabbari, Vivian K Weinberg, Katsuto Shinohara, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation studyJeff M Michalski, Kyounghwa Bae, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|December 3, 2002
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: a secondary analysis of the randomized protocol RTOG 86-10William U Shipley, J D Lu, Michael V Pilepich, et al.
International Journal of Radiation Oncology, Biology, Physics|April 5, 2011
Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trialsDaniel A Hamstra, Kyounghwa Bae, Miljenko V Pilepich, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2007
An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactionsColleen A Lawton, Michelle DeSilvio, Mack Roach, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2012
Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancerCharles C Hsu, Howard Hsu, Barby Pickett, et al.
Pageof 29